CHEMOTHERAPY IN METASTASIZED PROSTATE-CANCER

被引：0
作者：
HEIMBACH, D
WIRTH, M
FROHMULLER, H
机构：
来源：
UROLOGE-AUSGABE A | 1991年 / 30卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Seventeen patients with metastasized hormone-resistant prostate cancer were treated between January 1986 and October 1989 with combination chemotheraphy at the Department of Urology, University of Wurzburg Medical School. In 1 of the 17 patients a complete remission lasting 4 months was observed. In 3 patients a partial remission was noted, and in 5 others stable disease for an average of 6.8 months occurred. Tumor progression was seen in 7 patients. In all 16 evaluable cases palliation of tumor pain was achieved with this kind of treatment. The role of chemotherapy in the treatment of metastasized prostate cancer is discussed.
引用
收藏
页码：329 / 332
页数：4
相关论文
共 27 条
[11]  
KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO
[12]  
2-L
[13]  
KASIMIS BS, 1983, CANCER TREAT REP, V67, P937
[14]  
LOGOTHETIS C J, 1990, Journal of Urology, V143, p309A
[15]  
MUSS HB, 1981, CANCER, V47, P1949, DOI 10.1002/1097-0142(19810415)47:8<1949::AID-CNCR2820470806>3.0.CO
[16]  
2-3
[17]  
REINER WG, 1979, J UROLOGY, V122, P183
[18]  
RUBBEN H, 1987, UROLOGE A, V26, P7
[19]  
SCHMIDT JD, 1983, CANCER PROSTATE KIDN, P397
[20]   CARCINOMA OF THE PROSTATE IN ISRAEL - SOME EPIDEMIOLOGICAL AND THERAPEUTIC CONSIDERATIONS [J].
SERVADIO, C ;
MUKAMEL, E ;
KAHAN, E .
PROSTATE, 1984, 5 (04) :375-382
123